| # | Title | Journal | Year | Citations |
|---|
| 1 | Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study | Clinical Cancer Research | 2020 | 132 |
| 2 | Cytogenetics and Molecular Genetics of Acute Lymphoblastic Leukemia | Hematology/Oncology Clinics of North America | 2009 | 115 |
| 3 | Protection Against Esophageal Cancer in Rodents With Lyophilized Berries: Potential Mechanisms | Nutrition and Cancer | 2006 | 109 |
| 4 | Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes | Clinical Cancer Research | 2010 | 108 |
| 5 | Genetic Modification of T Cells Redirected toward CS1 Enhances Eradication of Myeloma Cells | Clinical Cancer Research | 2014 | 103 |
| 6 | A Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma | Clinical Cancer Research | 2006 | 100 |
| 7 | MicroRNAs activate natural killer cells through Toll-like receptor signaling | Blood | 2013 | 82 |
| 8 | Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer | JAMA - Journal of the American Medical Association | 2022 | 81 |
| 9 | A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma | Annals of Oncology | 2015 | 67 |
| 10 | Cumulative Risk Impact of Five Genetic Variants Associated with Papillary Thyroid Carcinoma | Thyroid | 2013 | 63 |
| 11 | Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial | Future Oncology | 2020 | 62 |
| 12 | COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer | Cancer Cell | 2022 | 61 |
| 13 | Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors | International Journal of Cancer | 2018 | 60 |
| 14 | Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice | Cancer | 2019 | 60 |
| 15 | Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with KRAS‐activated tumors | Cancer | 2016 | 55 |
| 16 | Colon Cancer | Surgical Oncology Clinics of North America | 2018 | 50 |
| 17 | Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute | Ca-A Cancer Journal for Clinicians | 2017 | 49 |
| 18 | BRAF V600E Mutation Analysis Simplifies the Testing Algorithm for Lynch Syndrome | American Journal of Clinical Pathology | 2013 | 46 |
| 19 | Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601 | European Journal of Cancer Care | 2017 | 45 |
| 20 | The use of ultrasound in the search for the primary site of unknown primary head and neck squamous cell cancers | Oral Oncology | 2014 | 44 |
| 21 | Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia | Leukemia and Lymphoma | 2013 | 41 |
| 22 | Cancer immune checkpoint blockade therapy and its associated autoimmune cardiotoxicity | Acta Pharmacologica Sinica | 2018 | 39 |
| 23 | Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries | Nature Genetics | 2023 | 39 |
| 24 | HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes | Scientific Reports | 2017 | 38 |
| 25 | IFN-γ gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice | Blood | 2005 | 35 |
| 26 | Tocilizumab for steroid refractory acute graft-versus-host disease | Leukemia and Lymphoma | 2016 | 35 |
| 27 | Transcervical Ultrasonography Is Feasible to Visualize and Evaluate Base of Tongue Cancers | PLoS ONE | 2014 | 34 |
| 28 | Quality Control for RNA-Seq (QuaCRS): An Integrated Quality Control Pipeline | Cancer Informatics | 2014 | 33 |
| 29 | High-Dose Pemetrexed in Combination with High-Dose Crizotinib for the Treatment of Refractory CNS Metastases in ALK-Rearranged Non–Small-Cell Lung Cancer | Journal of Thoracic Oncology | 2013 | 31 |
| 30 | Breast Cancer Hormone Receptor Assay Results of Core Needle Biopsy and Modified Radical Mastectomy Specimens From the Same Patients | Clinical Breast Cancer | 2010 | 30 |
| 31 | Targeting the IL-6 Dependent Phenotype Can Identify Novel Therapies for Cholangiocarcinoma | PLoS ONE | 2010 | 29 |
| 32 | Viral exanthems: An update on laboratory testing of the adult patient | Journal of the American Academy of Dermatology | 2017 | 29 |
| 33 | Formulation and In Vitro-In Vivo Evaluation of Black Raspberry Extract-Loaded PLGA/PLA Injectable Millicylindrical Implants for Sustained Delivery of Chemopreventive Anthocyanins | Pharmaceutical Research | 2010 | 28 |
| 34 | Creation of a Network to Promote Universal Screening for Lynch Syndrome: The Lynch Syndrome Screening Network | Journal of Genetic Counseling | 2015 | 28 |
| 35 | Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma | JAMA Oncology | 2021 | 28 |
| 36 | Understanding the molecular basis of imatinib mesylate therapy in chronic myelogenous leukemia and the related mechanisms of resistance. Commentary re: A. N. Mohamed et al., The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations. Clin. Cancer Res., 9: 1333-1337, 2003 | Clinical Cancer Research | 2003 | 28 |
| 37 | The Undergraduate Training in Genomics (UTRIG) Initiative: early & active training for physicians in the genomic medicine era | Personalized Medicine | 2018 | 25 |
| 38 | Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work | Ca-A Cancer Journal for Clinicians | 2021 | 25 |
| 39 | An immunological perspective for preventing cancer with berries | Journal of Berry Research | 2018 | 23 |
| 40 | Defining a global research agenda for breast cancer | Cancer | 2008 | 20 |
| 41 | Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop | Public Health Genomics | 2018 | 20 |
| 42 | Immunophenotyping by Mass Cytometry | Methods in Molecular Biology | 2019 | 18 |
| 43 | Could Aspirin and Diets High in Fiber Act Synergistically to Reduce the Risk of Colon Cancer in Humans? | International Journal of Molecular Sciences | 2018 | 16 |
| 44 | Yttrium-90 microsphere selective internal radiation therapy for liver metastases following systemic chemotherapy and surgical resection for metastatic adrenocortical carcinoma | World Journal of Clinical Oncology | 2018 | 14 |
| 45 | Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy | Blood and Lymphatic Cancer: Targets and Therapy | 2020 | 14 |
| 46 | New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: Cancer and leukemia group B 8461 | Genes Chromosomes and Cancer | 2013 | 13 |
| 47 | Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer: 13-Year Follow-Up | Annals of Surgical Oncology | 2019 | 13 |
| 48 | Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis | Frontiers in Oncology | 2016 | 12 |
| 49 | Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience | Leukemia and Lymphoma | 2019 | 12 |
| 50 | Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women’s health initiative | BMC Cancer | 2017 | 10 |
